Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported first-quarter FY23 revenues of $319.29 million, up 49.7% year over year, beating the consensus of…
Upbound Group, Inc. (NASDAQ:UPBD) reported first-quarter FY23 revenues of $1.02 billion, beating the consensus of $994.16 million. Revenues fell 12.4%…
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares are up Thursday as its Q1 results surpassed estimates. The company looks forward to sharing new interim data from NTLA-2001 and NTLA-2002 first-in-human studies in the coming months.
Hyatt Hotels Corp (NYSE: H) shares are down Thursday morning following its mixed Q1 performance. The company said its outlook remains optimistic, citing favorable booking trends.